Preclinical evaluation of EPC-001, a fully human anti-CD19 and CD22 bispecific tandem CAR-T April 13, 2022
CFT-8634, a novel BRD9 degrader with promising efficacy in PDX models of synovial sarcoma April 13, 2022
In vivo imaging of integrin beta-2 activation enabled with humanized integrin beta-2 knockin mice April 13, 2022
Lieber Institute, Johns Hopkins University present DNA-directed RNA polymerase I inhibitors April 13, 2022